32.00p-4.00 (-11.11%)20 Jan 2022, 16:35
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Oxford Biodynamics PLC Fundamentals

Company NameOxford Biodynamics PLCLast Updated2022-01-20
IndustryBiotechnologySectorHealthcare
Shares in Issue100.352 mMarket Cap£32.11 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-£0.05EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0.0391Debt Equity Ratio0.0330
Asset Equity Ratio1.1579Cash Equity Ratio0.7715
Quick Ratio7.4583Current Ratio7.77
Price To Book Value3.0469ROCE0

Oxford Biodynamics PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Oxford Biodynamics PLC Company Financials

Assets20202019
Tangible Assets£1.18 m£891,000.00
Intangible Assets£869,000.00£555,000.00
Investments£422,000.00£422,000.00
Total Fixed Assets£2.47 m£1.87 m
Stocks£323,000.00£243,000.00
Debtors£445,000.00£584,000.00
Cash & Equivalents£11.51 m£15.50 m
Other Assets00
Total Assets£15.35 m£18.79 m
Liabilities20202019
Creditors within 1 year£1.29 m£1.11 m
Creditors after 1 year£485,000.00£92,000.00
Other Liabilities00
Total Liabilities£1.77 m£1.20 m
Net assets£13.58 m£17.59 m
Equity20202019
Called up share capital£926,000.00£926,000.00
Share Premium£16.74 m£16.74 m
Profit / Loss-£4.91 m-£3.39 m
Other Equity£13.56 m£17.57 m
Preference & Minorities£18,000.00£19,000.00
Total Capital Employed£13.58 m£17.59 m
Ratios20202019
Debt Ratio£0.030
Debt-to-Equity£0.030
Assets / Equity1.15791.1579
Cash / Equity0.77150.7715
EPS-£0.05-£0.03
Cash Flow20202019
Cash from operating activities-£3.40 m-£2.27 m
Cashflow before financing-£3.58 m-£2.04 m
Increase in Cash£998,000.00-£13.22 m
Income20202019
Turnover£456,000.00£907,000.00
Cost of sales£622,000.00£468,000.00
Gross Profit-£166,000.00£439,000.00
Operating Profit-£4.95 m-£3.72 m
Pre-Tax profit-£4.91 m-£3.39 m

Oxford Biodynamics PLC Company Background

SectorHealthcare
ActivitiesOxford BioDynamics PLC is a biotechnology company. The company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. The firm provides a technology platform Episwitch which aims to accelerate the drug discovery and development process and improve the success rate of therapeutic product development.
Latest Interim Date15 Jun 2021
Latest Fiscal Year End Date25 Jan 2022

Oxford Biodynamics PLC Directors

AppointedNamePosition
2019-03-13Mr. David Jefferys WilliamsNon-Executive Director,Chairman
2021-02-23Dr. David Mark Anthony HolbrookNon-Executive Director
2020-12-30Mr. Christian Gurth Hoyer Millar Executive Director
2021-02-23Dr. Alexandre Akoulitchev Executive Director,Chief Scientific Officer
2021-12-13Mr. Stephen Charles Diggle Non-Executive Director
2021-12-01Mr. Paul Leslie StockdaleExecutive Director,Chief Financial Officer
2020-12-14Mr. Peter Pack Non-Executive Director,Chairman
2021-05-14Dr. Jon Anthony Joseph BurrowsExecutive Director,Group Chief Executive Officer
2021-12-24Mr. Matthew Anthony WakefieldNon-Executive Director,Chairman

Oxford Biodynamics PLC Contact Details

Company NameOxford BioDynamics PLC
Address26 Beaumont Street, Oxford, OX1 2NP
Telephone+44 1865518910
Websitehttps://www.oxfordbiodynamics.com

Oxford Biodynamics PLC Advisors

StockbrokerShore Capital Stockbrokers Ltd
Phone+44 2074084050
Fax+44 2074084091
BankHSBC Bank PLC
SolicitorMayer Brown International LLP
Phone+44 2031303000
Fax+44 2031303001
AuditorKPMG
Phone+44 1189642000
Fax+44 1189642222
RegistrarCapita Asset Services
Phone+44 8716640300
Fax+44 2086392342
Financial PR AdviserFTI Consulting Inc
Phone+44 2037271000
Fax+44 2037271007
Nominated AdviserStifel Nicolaus Europe Ltd
Phone+44 2077107600
Fax+44 2077107609
StockbrokerStifel Nicolaus Europe Ltd
Phone+44 2077107600
Fax+44 2077107609
Financial PR AdviserConsilium Strategic Communications
Phone+44 2037095700